Min Sik Bae

Title: Inventor Min Sik Bae: Pioneer of Piperidinedione Derivatives

Introduction

Min Sik Bae, based in Yongin-si, South Korea, is an innovative inventor known for his contributions in the field of pharmaceuticals. He holds a patent that showcases a novel piperidinedione compound, which has the potential to revolutionize treatments for various diseases.

Latest Patents

Min Sik Bae's patent focuses on piperidinedione derivatives, specifically disclosing a unique compound of Formula 1 or a pharmaceutically acceptable salt thereof. This compound has significant implications as an anti-tumor agent and immunomodulatory for the treatment of CRBN protein-mediated diseases. Moreover, it can serve as an E3 ligase binder in a PROTAC compound, which comprises a protein of interest ligand, a linker, and the E3 ligase binder, indicating its versatility and potential impact in therapeutic applications.

Career Highlights

Currently, Min Sik Bae is affiliated with Innocure Therapeutics, Inc., where he utilizes his expertise to advance innovative pharmaceutical solutions. His research and development focus has positioned him as a crucial contributor in the biotechnology sector, emphasizing the importance of his discoveries in medical treatments.

Collaborations

Throughout his career, Min Sik Bae has collaborated with notable coworkers such as Hye-Dong Yoo and Young-jun Shin. These partnerships have fostered a productive research environment, further enhancing the development and practical applications of his innovations.

Conclusion

Min Sik Bae is a dedicated inventor whose work on piperidinedione derivatives stands at the forefront of medical research. His contributions hold promise for significant advancements in treating complex diseases, highlighting the essential role of inventors in the ever-evolving healthcare landscape.